A comparative study of inhaled atropine sulfate and isoproterenol hydrochloride in cystic fibrosis.
D000293:Adolescent; D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D002648:Child; D003550:Cystic Fibrosis / Q000503:physiopathology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008448:Maximal Expiratory Flow Rate; D008449:Maximal Expiratory Flow-Volume Curves; D012115:Residual Volume; D012119:Respiration / Q000187:drug effects*; D014109:Total Lung Capacity; D014797:Vital Capacity
D000336:Aerosols; D001285:Atropine; D007545:Isoproterenol